v3.25.4
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Sep. 30, 2025
Summary of Significant Accounting Policies [Abstract]  
Schedule of Inventory

Inventory is stated at the lower of actual accumulated costs or net realizable value as of September 30, 2025 and 2024 related to the manufacturing of LYMPHIR commercial products, which were available for sale commencing in December 2025. No reserves against inventory were deemed necessary based on an evaluation of the product expiration dating.

 

   2025   2024 
Finished goods  $10,577,876   $6,134,895 
Work in process   11,708,817    2,133,871 
Total  $22,286,693   $8,268,766